Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03324282 |
Title | First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma (GCISAVE) |
Acronym | GCISAVE |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University Hospital, Bordeaux |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
CHU de Besançon | Besançon | France | Details | |||
CHU de Bordeaux | Bordeaux | France | Details | |||
Institut Bergonié | Bordeaux | France | Details | |||
Centre François Baclesse | Caen | France | Details | |||
Centre Léon Bérard | Lyon | France | Details | |||
Institut Paoli Calmettes | Marseille | France | Details | |||
Institut de cancérologie de l'Ouest - René Gauducheau | Nantes | France | Details | |||
Hôpital Européen Georges-Pompidou, AP-HP | Paris | France | Details | |||
Hôpital Saint-Louis, AP-HP | Paris | France | Details | |||
CHU de Poitiers | Poitiers | France | Details | |||
CHU de Strasbourg | Strasbourg | France | Details | |||
Institut Universitaire du Cancer de Toulouse - Oncopole | Toulouse | France | Details | |||
Institut Gustave Roussy | Villejuif | France | Details |